Search research articles
Contact Us
Filters
Showing results (521-530 of 583) with videos related to
Page
of 59
Sort By:
Journal of Hematology & Oncology
|
June 6, 2024
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
Saurabh Zanwar, Surbhi Sidana, Leyla Shune, et al.
JAMA Oncology
|
April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant
Qamar J Khan, Cory R Bivona, Grace A Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
Miriam T Jacobs, Michael D Jain, Feng Gao, et al.
Oncogene
|
February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
Haematologica
|
September 21, 2023
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
Surbhi Sidana, Lauren C Peres, Hamza Hashmi, et al.
Blood
|
July 22, 2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Blood Advances
|
September 8, 2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome
Alex F Herrera, Kwang Woo Ahn, Carlos Litovich, et al.
Eclinicalmedicine
|
May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Page
of 59
Search research articles
Search
Showing results (521-530 of 583) with videos related to
Sort By:
Page
of 59
Journal of Hematology & Oncology
|
June 6, 2024
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
Saurabh Zanwar, Surbhi Sidana, Leyla Shune, et al.
JAMA Oncology
|
April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant
Qamar J Khan, Cory R Bivona, Grace A Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
Miriam T Jacobs, Michael D Jain, Feng Gao, et al.
Oncogene
|
February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
Haematologica
|
September 21, 2023
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
Surbhi Sidana, Lauren C Peres, Hamza Hashmi, et al.
Blood
|
July 22, 2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Blood Advances
|
September 8, 2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome
Alex F Herrera, Kwang Woo Ahn, Carlos Litovich, et al.
Eclinicalmedicine
|
May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Page
of 59